(Q43094420)

13 November 2017

title

Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats (English)

1 reference

13 November 2017

0 references

0 references

Naila Ismayilova

1

1 reference

13 November 2017

Mohammed Shoaib

series ordinal

2

1 reference

13 November 2017

publication date

17 April 2010

1 reference

13 November 2017

1 reference

13 November 2017

volume

210

1 reference

13 November 2017

issue

2

1 reference

13 November 2017

page(s)

211-220

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-010-1845-4

13 November 2017

exact match

0 references

cites work

Modulation of kappa-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00213-010-1845-4

Nicotine maintains robust self-administration in rats on a limited-access schedule

21 January 2018

1 reference

12 December 2020

Nicotine self-administration in rats

1 reference

12 December 2020

Aversive properties of naloxone in non-dependent (naive) rats may involve blockade of central beta-endorphin.

1 reference

12 December 2020

Cue reactivity in nicotine and tobacco dependence: a "multiple-action" model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli

1 reference

12 December 2020

Naltrexone alteration of acute smoking response in nicotine-dependent subjects.

1 reference

12 December 2020

Opiate antagonists reduce cocaine but not nicotine self-administration.

1 reference

12 December 2020

The effects of sertraline on nicotine self-administration and food-maintained responding in squirrel monkeys.

1 reference

12 December 2020

The scientific case that nicotine is addictive.

1 reference

12 December 2020

Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats

1 reference

12 December 2020

Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain

1 reference

12 December 2020

Evidence for opioid mechanisms in the behavioral effects of nicotine

1 reference

12 December 2020

Opposite motivational effects of endogenous opioids in brain and periphery

1 reference

12 December 2020

Naloxone does not affect cigarette smoking

1 reference

12 December 2020

Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers.

1 reference

12 December 2020

Cue dependency of nicotine self-administration and smoking.

1 reference

12 December 2020

Epidemiology of tobacco use in the United States

1 reference

12 December 2020

Effect of naloxone on cigarette smoking

1 reference

12 December 2020

A randomized trial of naltrexone for smoking cessation.

1 reference

12 December 2020

Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone

1 reference

12 December 2020

Discriminative stimulus effects of nicotine and chronic tolerance.

1 reference

12 December 2020

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

1 reference

12 December 2020

Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat.

1 reference

12 December 2020

Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats.

1 reference

12 December 2020

Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal

1 reference

12 December 2020

Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration

1 reference

12 December 2020

Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys

1 reference

12 December 2020

Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices

1 reference

12 December 2020

Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine

1 reference

12 December 2020

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

12 December 2020

Design of peptidomimetic delta opioid receptor antagonists using the message-address concept

1 reference

12 December 2020

The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats

1 reference

12 December 2020

Nicotine self-administration in animals as a dependence model

1 reference

12 December 2020

A laboratory study of hydromorphone and cyclazocine on smoking behavior in residential polydrug users

1 reference

12 December 2020

Naltrexone, smoking behaviour and cigarette withdrawal.

1 reference

12 December 2020

Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats

1 reference

12 December 2020

Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.

1 reference

12 December 2020

Nicotine self-administration in rats: strain and nicotine pre-exposure effects on acquisition.

1 reference

12 December 2020

Mu-opioid receptor and CREB activation are required for nicotine reward

1 reference

12 December 2020

Morphine, pentazocine and naloxone effects on responding under a multiple schedule of reinforcement in rhesus monkeys and pigeons

1 reference

12 December 2020

Naloxone as a negative reinforcer in rhesus monkeys: effects of dose, schedule, and narcotic regimen.

1 reference

12 December 2020

Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans

1 reference

12 December 2020

Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection

1 reference

12 December 2020

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

12 December 2020

Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.

1 reference

12 December 2020

Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.

1 reference

12 December 2020

The GABA B receptor agonists baclofen and CGP44532 decreased nicotine self-administration in the rat

1 reference

12 December 2020

Kappa-opioid receptor modulation of nicotine-induced behaviour

1 reference

12 December 2020

The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine

1 reference

12 December 2020

The neurobiology of tobacco addiction

1 reference

12 December 2020

Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area

1 reference

12 December 2020

Current pharmacological treatments for nicotine dependence

1 reference

12 December 2020

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

1 reference

12 December 2020

Naloxone reduces cigarette smoking

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S00213-010-1845-4

Identifiers

DOI

1 reference

Dimensions Publication ID

13 November 2017

1007660334

0 references

1 reference